Next Article in Journal
Evaluation of the Bioactivity of Novel Spiroisoxazoline TypeCompounds against Normal and Cancer Cell Lines
Previous Article in Journal
Synthesis of New Racemic α,α-Diaminocarboxylic Ester Derivatives
Article Menu

Article Versions

Export Article

Open AccessArticle
Molecules 2010, 15(12), 9364-9379; doi:10.3390/molecules15129364

Molecular Modeling Studies on 11H-Dibenz[b,e]azepine and Dibenz[b,f][1,4]oxazepine Derivatives as Potent Agonists of the Human TRPA1 Receptor

1
College of Pharmacy, South Central University for Nationalities, 708 Minyuan Road, Wuhan 430074, China
2
College of Life Sciences, South Central University for Nationalities, 708 Minyuan Road, Wuhan 430074, China
3
Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China
These authors contributed equally to this work.
*
Author to whom correspondence should be addressed.
Received: 22 November 2010 / Revised: 8 December 2010 / Accepted: 15 December 2010 / Published: 17 December 2010
Download PDF [271 KB, uploaded 18 June 2014]

Abstract

A computational strategy based on comparative molecular fields analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) was performed on a series of the 11H-dibenz[b,e]azepine and dibenz[b,f][1,4]oxazepine derivatives as potent agonists of the human TRPA1 receptor. The CoMFA and CoMSIA models resulting from a 21 molecule training set gave r2cv values of 0.631 and 0.542 and r2 values of 0.986 and 0.981, respectively. The statistically significant models were validated by a test set of five compounds with predictive r2pred. values of 0.967 and 0.981 for CoMFA and CoMSIA, respectively. A systemic external validation was also performed on the established models. The information obtained from 3D counter maps could facilitate the design of more potent human TRPA1 receptor agonists.
Keywords: 11H-dibenz[b,e]azepines; dibenz[b,f][1,4]oxazepines; CoMFA; CoMSIA; TRPA1 11H-dibenz[b,e]azepines; dibenz[b,f][1,4]oxazepines; CoMFA; CoMSIA; TRPA1
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Ai, Y.; Song, F.-J.; Wang, S.-T.; Sun, Q.; Sun, P.-H. Molecular Modeling Studies on 11H-Dibenz[b,e]azepine and Dibenz[b,f][1,4]oxazepine Derivatives as Potent Agonists of the Human TRPA1 Receptor. Molecules 2010, 15, 9364-9379.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top